AI assistant
Novonesis AS — Director's Dealing 2009
Dec 7, 2009
3377_rpt_2009-12-07_8755ca47-ae8b-435e-9215-d35ba9da4475.pdf
Director's Dealing
Open in viewerOpens in your device viewer
TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES
December 7, 2009
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
| Name | Relation/ Category of close relation |
Trading date | Character of the transaction |
No. of shares traded Buy (+) / Sell (-) |
Market value of shares traded (DKK) |
|---|---|---|---|---|---|
| Ulla Morin | Employee representative of BoD |
4/12 2009 | Share options | + 300 - 300 |
55,800 150,156 |
Contact persons:
Press and media: Investor relations:
Annegrethe M. Jakobsen (Europe) Tel. (direct): +45 4446 3050 Tel. (mobile): +45 3077 3050
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Tobias Bjørklund Tel. (direct): +45 4446 8682 Tel. (mobile): +45 3077 8682
Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 16, 2009 Page 1 of 1 Novozymes A/S Investor Relations Denmark
Krogshøjvej 36 2880 Bagsværd
Telephone: +45 4446 0000 Fax: +45 4446 9999
Internet: www.novozymes.com CVR number: 10 00 71 27